Skip to main content
OpenTrials

Clinical trial condition

Restless Legs Syndrome

Explore clinical trials studying Restless Legs Syndrome. Study availability and eligibility vary by location and protocol.

148 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Restless Legs Syndrome trial results

Completed

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

NCT00314860

Conditions
Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Sun City, Arizona, United States
View all 91 locations
View Trial Details
Completed

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome

NCT00363857

Conditions
Dyssomnias, Fatigue, Mental Disorders, +9 more
Locations
  • GSK Investigational Site Alabaster, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Tuscaloosa, Alabama, United States
View all 49 locations
View Trial Details
Completed

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

NCT00197080

Conditions
Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations
  • GSK Investigational Site Alabaster, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Peoria, Arizona, United States
View all 70 locations
View Trial Details
Completed

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

NCT00225862

Conditions
Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations
  • GSK Investigational Site Alabaster, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Peoria, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 37 locations
View Trial Details
Completed

A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis

NCT01537042

Conditions
Chronic Disease, Disease Attributes, Dyssomnias, +18 more
Locations
  • 606 Brandon, Florida, United States
  • 604 Newton, Massachusetts, United States
  • 603 West Seneca, New York, United States
  • 607 Dublin, Ohio, United States
View all 15 locations
View Trial Details

Related conditions